Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Single cell RNA-seq data for MOC1 tumors

ABSTRACT: single cell RNA-seq data for MOC1 tumors

PROVIDER: PRJNA800782 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR17770072_1.fastq.gz	Fastqsanger.gz
	SRR17770072_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 2 of 2

Similar Datasets

single cell RNA-seq data for MOC1 tumors

Project description:Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide, with 5-year survival of ~50%. Genomic profiling studies have identified important somatic mutations in this disease which presents an opportunity for precision medicine. We demonstrate that KMT2D, a histone methyltransferase harbors somatic mutations in ~17% of HNSCC and is associated with 2-year recurrence in TCGA data. Consistent with algorithmic prediction of bring a driver tumor-suppressor event, its loss results in larger oral tumors in immune-proficient orthotopic models. Mechanistically, we find that KMT2D knockdown or KMT2D mutation causes loss of H3K4me1-marked enhancers harboring IRF7/9 binding sites, which is known to regulate interferon signaling. Indeed, KMT2D loss in human and murine cell lines deregulated transcriptional levels of cytokine expression and impacted numerous immune signaling pathways, including interferon signaling. Consistently, Kmt2d knockdown in murine tumors exhibited decrease in IFN-producing effector T cells and an increase in T-cells with an exhausted phenotype. Epistasis experiments showed that exogenous treatment with IFN abrogated the increased tumor growth in Kmt2d-deficient oral tumors. Together, these results support the role of KMT2D as a tumor suppressor in HNSCC that regulates the tumor microenvironment by modulating H3K4me1-marked enhancers controlling interferon signaling.

2025-01-26 | GSE195481 | GEO

Gene expression profile of different cell types in the tumor microenvironment of MOC1 tumors treated with Smyd3 anti-sense oligonucleotides (ASOs).

Project description:We used scRNA-seq to assess the differential effect of Smyd3 ASOs on the transcriptomic profile of different cell types in the TME of MOC1 tumors.

2024-10-10 | GSE273507 | GEO

Gene expression profile of different cell types in the tumor microenvironment of MOC1 tumors that responded or not to treatment with Smyd3 ASOs and anti-PD-1 combination therapy.

Project description:We used scRNA-seq to assess the transcriptomic differences in the different cell types of the TME of MOC1 tumors that responded or not to Smyd3 ASOs and anti-PD-1 combination therapy.

2024-10-10 | GSE273508 | GEO

Transcriptional profiling of tumor infiltrating and ciculating T lymphocytes of mice harboring MOC1 tumors

Project description:Transcriptional profiling of tumor infiltrating and ciculating T lymphocytes of mice harboring MOC1 tumors

| PRJNA1129111 | ENA

Single cell RNA-seq of 4T1 mammary tumors

Project description:Single cell RNA-seq of 4T1 mammary tumors

| PRJNA962048 | ENA

Single-cell transcriptomics of neuroblastoma tumors

Project description:Single-cell transcriptomics of neuroblastoma tumors

| PRJNA1067585 | ENA

Retinoblastoma tumors NGS data

Project description:Retinoblastoma tumors NGS data